Living Labs In Clinical Research: current status, challenges & future perspectives

A lot of Health and Wellbeing LLs are operating in various settings and infrastructures such as clinical setting, lab environments, distributed setting (e.g. homes, care centers) and also engaging various stakeholders from the quadruple helix in all processes. LLs also include innovative methodologies and an agile, user-centric view on designing and validating interventions.

Clinical trials are designed to answer specific questions about biomedical or behavioral interventions, including new treatments and should have clear and well-structured outcomes about efficacy, safety, efficiency, effectiveness and more and follow specific regulations. Depending on product type and development stage, investigators initially enroll volunteers or patients into small pilot studies, and subsequently conduct progressively larger scale comparative studies. These are some of the questions that will be addressed during this panel.


10.00 – 10.05 Welcome and objectives – Despoina Petsani & Evdokimos Konstantinidis

10.05 – 10.15 The objectives of Health and Wellbeing AOTF – Panos Bamidis

10.15 – 11.05 Panel discussion moderated by HOLTEL Andreas (senior administrator

responsible for the majority of current health infrastructures projects, REA C.4)

● Jacques Demotes, Director General of the European Clinical Research Infrastructure

Network (ECRIN)

● Nico Gariboldi, Site Lead – Global Center for Digital Innovation – Senior Director at

Pfizer, Rome Area, Italy

● Ingrid Adriaensen, Businesses and Organizations innovation manager, Health Living

Labs, LicaLab, ThomasMore

● Hadas Lewy, Head of Digital Health Ventures Research, Innovation and International

Ventures Authority, Digital Medical Technology Department, Holon Institute of

Technology, Israel

● Jan-Willem van de Loo, Policy and Scientific Officer at the European Commission in charge of cancer


11.05 – 11.15 Q&A


Evdokimos Konstantinidis

President, European Network of Living Labs, Thess-AHALL Researcher,